Abstract
Cancer is the result of cumulative multiple genetic mutations, which result in the activation of oncogenes and / or the inactivation of tumor suppressor genes. Current theories of malignant transformation postulate that the development of primary brain tumors is the consequence of the sequential accumulation of multiple genetic alterations in brain cells, each of which contributes to the induction of a progressively more malignant phenotype. Traditionally, our understanding of brain tumor biology has come from the study of single specific genes or chromosome regions at a time. Although several genetic aberrations and gene expression changes have been identified using such focused techniques, the traditional methods of cancer research are tediously slow and provide limited insight into the global gene expression patterns that occur during the malignant transformation, development, and progression of primary brain cancers. Because hundreds of genes may be simultaneously involved in the mechanisms of ca rcinogenesis, new genomic high-throughput technologies have recently come into the forefront of cancer research. These technologies, which include cDNA and oligonucleotide microarrays (gene chips) and tissue microarray (tissue chip) techniques, may considerably facilitate the molecular profiling of human tumors. Such molecular fingerprinting of malignant gliomas, for example, may lead to advances in diagnosis, prognosis, and design of novel therapeutic approaches that could improve the clinical outcome of patients suffering from this rapidly fatal disease. This review will describe the principles of microarray technology as applied to human brain tumor research, summarize its use and limitations in identifying brain tumor-associated genes thus far, and speculate on the future applications and clinical ramifications of such genomic large-scale screening techniques in neuro-oncology.
Keywords: Microarrays, Brain Tumors, cancer, cdna microarrays, tissue microarray tma analysis, insulin-like growth, protein2 1gfbp2, facetor binding gene
Current Genomics
Title: Microarrays and the Genetic Analysis of Brain Tumors
Volume: 3 Issue: 1
Author(s): L. M. Liau and I. Yang
Affiliation:
Keywords: Microarrays, Brain Tumors, cancer, cdna microarrays, tissue microarray tma analysis, insulin-like growth, protein2 1gfbp2, facetor binding gene
Abstract: Cancer is the result of cumulative multiple genetic mutations, which result in the activation of oncogenes and / or the inactivation of tumor suppressor genes. Current theories of malignant transformation postulate that the development of primary brain tumors is the consequence of the sequential accumulation of multiple genetic alterations in brain cells, each of which contributes to the induction of a progressively more malignant phenotype. Traditionally, our understanding of brain tumor biology has come from the study of single specific genes or chromosome regions at a time. Although several genetic aberrations and gene expression changes have been identified using such focused techniques, the traditional methods of cancer research are tediously slow and provide limited insight into the global gene expression patterns that occur during the malignant transformation, development, and progression of primary brain cancers. Because hundreds of genes may be simultaneously involved in the mechanisms of ca rcinogenesis, new genomic high-throughput technologies have recently come into the forefront of cancer research. These technologies, which include cDNA and oligonucleotide microarrays (gene chips) and tissue microarray (tissue chip) techniques, may considerably facilitate the molecular profiling of human tumors. Such molecular fingerprinting of malignant gliomas, for example, may lead to advances in diagnosis, prognosis, and design of novel therapeutic approaches that could improve the clinical outcome of patients suffering from this rapidly fatal disease. This review will describe the principles of microarray technology as applied to human brain tumor research, summarize its use and limitations in identifying brain tumor-associated genes thus far, and speculate on the future applications and clinical ramifications of such genomic large-scale screening techniques in neuro-oncology.
Export Options
About this article
Cite this article as:
Liau M. L. and Yang I., Microarrays and the Genetic Analysis of Brain Tumors, Current Genomics 2002; 3 (1) . https://dx.doi.org/10.2174/1389202023350633
DOI https://dx.doi.org/10.2174/1389202023350633 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metallodrugs in Targeted Cancer Therapeutics: Aiming at Chemoresistance- related Patterns and Immunosuppressive Tumor Networks
Current Medicinal Chemistry How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments
Current Pharmaceutical Design The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Current Genomics Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes
Current Pharmaceutical Design Identification of Biomarkers and Functional Modules from Genomic Data in Stage-wise Breast Cancer
Current Bioinformatics Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets Medicinal Plants for Glioblastoma Treatment
Anti-Cancer Agents in Medicinal Chemistry Genomic Instability in Cancer: Molecular Mechanisms and Therapeutic Potentials
Current Pharmaceutical Design Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors
Current Topics in Medicinal Chemistry Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents
Current Topics in Medicinal Chemistry Fungal Bioactive Compounds in Pharmaceutical Research and Development
Current Bioactive Compounds Targeted Nanosystems for Cancer Therapy
Current Cancer Therapy Reviews Drugging Cell Cycle Kinases in Cancer Therapy
Current Drug Targets Expression of Opioid Receptors During Peripheral Inflammation
Current Topics in Medicinal Chemistry MiRNAs in Human Cancers: The Diagnostic and Therapeutic Implications
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Neuropharmacology HSP27: Mechanisms of Cellular Protection Against Neuronal Injury
Current Molecular Medicine